A Study For Outpatients With COVID-19

Drug studies often look at the effect one or two drugs have on a medical condition, and involve one company. There is currently an urgent need for one study to efficiently test multiple drugs from more than one company, in people who have tested positive for COVID-19 but who do not currently need hospitalization.

Carolina Clinical Research is currently seeking study participants 18 years and older, with a recent COVID-19 diagnosis (within the last 8 days).

This study is currently sponsored by the National Institute of Allergy and Infectious Diseases (NIAD), in collaboration with Eli Lilly and Company and the AIDS Clinical Trial Group.